Patents by Inventor Anton Beletskii

Anton Beletskii has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10131874
    Abstract: A cell culture support comprising a substrate, and a dual stimuli responsive block copolymer immobilized on the substrate, wherein the dual stimuli responsive block copolymer is both thermoresponsive and pH responsive. A method of culturing cells comprising the cell culture support having a dual stimuli responsive copolymer immobilized on a substrate, wherein the dual stimuli responsive copolymer is thermoresponsive and pH responsive; and growing the cells on the cell culture support. By lowering the temperature, cells are released from the cell culture support.
    Type: Grant
    Filed: September 12, 2016
    Date of Patent: November 20, 2018
    Assignee: GENERAL ELECTRIC COMPANY
    Inventors: Reginald Donovan Smith, Prameela Susarla, Slawomir Rubinsztajn, Brian David Polizzotti, Anton Beletskii
  • Publication number: 20160376550
    Abstract: A cell culture support comprising a substrate, and a dual stimuli responsive block copolymer immobilized on the substrate, wherein the dual stimuli responsive block copolymer is both thermoresponsive and pH responsive. A method of culturing cells comprising the cell culture support having a dual stimuli responsive copolymer immobilized on a substrate, wherein the dual stimuli responsive copolymer is thermoresponsive and pH responsive; and growing the cells on the cell culture support. By lowering the temperature, cells are released from the cell culture support.
    Type: Application
    Filed: September 12, 2016
    Publication date: December 29, 2016
    Inventors: Reginald Donovan Smith, Prameela Susarla, Slawomir Rubinsztajn, Brian David Polizzotti, Anton Beletskii
  • Patent number: 9469839
    Abstract: A cell culture support comprising a substrate, and a dual stimuli responsive block copolymer immobilized on the substrate, wherein the dual stimuli responsive block copolymer is both thermoresponsive and pH responsive. A method of culturing cells comprising the cell culture support having a dual stimuli responsive copolymer immobilized on a substrate, wherein the dual stimuli responsive copolymer is thermoresponsive and pH responsive; and growing the cells on the cell culture support. By lowering the temperature, cells are released from the cell culture support.
    Type: Grant
    Filed: June 29, 2009
    Date of Patent: October 18, 2016
    Assignee: General Electric Company
    Inventors: Slawomir Rubinsztajn, Prameela Susarla, Anton Beletskii, Reginald Donovan Smith, Brian Polizzotti
  • Publication number: 20120208268
    Abstract: The present invention relates to a separation media and a method for separation of cells from different cell sources, such as umbilical cord blood, using the separation media to obtain the desired cells, such as stem cells. The separation media has beads with a diameter of 200-500 ?m and is provided with cell separation ligands. The cell specific ligands are preferably CD3 and CD19 for depletion of B and T cells and production of a stem cell rich product.
    Type: Application
    Filed: April 26, 2012
    Publication date: August 16, 2012
    Applicant: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: ANDREAS AXÉN, ANTON BELETSKII, FREDRIK ELWINGER, GUNNAR HAGSTRÖM, DEIDRE A. NELSON
  • Publication number: 20120156777
    Abstract: A carrier for growing adherent cells is provided, wherein the carrier comprises one or more outer surfaces; and one or more structured indentations on one or more of the outer surfaces, wherein the carrier has a length at least about 0.2 mm, a width at least about 0.2 mm, and a height in a range from about 0.05 mm to 1.2 mm and each of the structured indentations has a major axis in a range from about 0.1 mm to 0.5 mm, a minor axis in a range from about 0.1 mm to 0.5 mm and a depth in a range from about 0.025 mm to about 0.5 mm. The carrier may comprise a single indentation or ‘cup’ like structure, or may comprise a plurality of indentations. A method of making the carrier, and culturing stromal cells using the same carrier are also provided.
    Type: Application
    Filed: December 16, 2010
    Publication date: June 21, 2012
    Applicant: GENERAL ELECTRIC COMPANY
    Inventors: Arvind Rangarajan, Prameela Susarla, Scott Michael Miller, Reginald Donovan Smith, Slawomir Rubinsztajn, Anton Beletskii
  • Patent number: 7906106
    Abstract: Provided herein are methods of monitoring inflammatory cell migration in a mammal. The methods include the steps of: providing a donor mammalian subject; introducing an inflammatory agent into the donor mammal to create a granuloma; isolating granuloma-derived nucleated cells from the granuloma of the donor mammalian subject; labeling the granuloma-derived nucleated cells with an optical agent; providing a recipient mammalian subject with inflamed tissue; introducing the granuloma-derived nucleated cells into a recipient mammalian subject at a site remote from site where the inflammatory agent was introduced; and imaging the recipient mammalian subject using an optical system. The methods may also include analysing the distribution of the labeled granuloma-derived cells in the recipient mammal.
    Type: Grant
    Filed: June 27, 2007
    Date of Patent: March 15, 2011
    Assignee: General Electric Company
    Inventors: Eric Dustin Agdeppa, Srabani Bhaumik, June Klimash, Jeannette Christine DePuy, Anton Beletskii
  • Publication number: 20100330674
    Abstract: A cell culture support comprising a substrate, and a dual stimuli responsive block copolymer immobilized on the substrate, wherein the dual stimuli responsive block copolymer is both thermoresponsive and pH responsive. A method of culturing cells comprising the cell culture support having a dual stimuli responsive copolymer immobilized on a substrate, wherein the dual stimuli responsive copolymer is thermoresponsive and pH responsive; and growing the cells on the cell culture support. By lowering the temperature, cells are released from the cell culture support.
    Type: Application
    Filed: June 29, 2009
    Publication date: December 30, 2010
    Applicant: GENERAL ELECTRIC COMPANY
    Inventors: Slawomir Rubinsztajn, Prameela Susarla, Anton Beletskii, Reginald Donovan Smith, Brian Polizzotti
  • Patent number: 7846735
    Abstract: Provided herein are compositions and methods for lipoprotein uptake assay. These compositions and methods may be used for lipoprotein uptake assays, including high-throughput assays. The disclosed compositions and method may further be used to characterize the activity agents that inhibit or stimulate lipoprotein uptake.
    Type: Grant
    Filed: August 22, 2007
    Date of Patent: December 7, 2010
    Assignee: General Electric Company
    Inventors: Anton Beletskii, Liming Lu, Jason William Castle
  • Publication number: 20100081121
    Abstract: The present invention relates to a separation media and a method for separation of cells from different cell sources, such as umbilical cord blood, using the separation media to obtain the desired cells, such as stem cells. The separation media has beads with a diameter of 200-500 ?m and is provided with cell separation ligands. The cell specific ligands are preferably CD3 and CD19 for depletion of B and T cells and production of a stem cell rich product.
    Type: Application
    Filed: January 28, 2008
    Publication date: April 1, 2010
    Applicant: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: Andreas Axen, Anton Beletskii, Fredrik Elwinger, Gunnar Hagstrom, Deidre A. Nelson
  • Publication number: 20090004115
    Abstract: Provided herein are methods of monitoring inflammatory cell migration in a mammal. The methods include the steps of: providing a donor mammalian subject; introducing an inflammatory agent into the donor mammal to create a granuloma; isolating granuloma-derived nucleated cells from the granuloma of the donor mammalian subject; labeling the granuloma-derived nucleated cells with an optical agent; providing a recipient mammalian subject with inflamed tissue; introducing the granuloma-derived nucleated cells into a recipient mammalian subject at a site remote from site where the inflammatory agent was introduced; and imaging the recipient mammalian subject using an optical system. The methods may also include analysing the distribution of the labeled granuloma-derived cells in the recipient mammal.
    Type: Application
    Filed: June 27, 2007
    Publication date: January 1, 2009
    Applicant: GENERAL ELECTRIC COMPANY
    Inventors: Eric Dustin Agdeppa, Srabani Bhaumik, June Klimash, Jeannette Christine DePuy, Anton Beletskii
  • Publication number: 20080044352
    Abstract: Provided herein are compositions and methods for lipoprotein uptake assay. These compositions and methods may be used for lipoprotein uptake assays, including high-throughput assays. The disclosed compositions and method may further be used to characterize the activity agents that inhibit or stimulate lipoprotein uptake.
    Type: Application
    Filed: August 22, 2007
    Publication date: February 21, 2008
    Applicant: GENERAL ELECTRIC COMPANY
    Inventors: Anton Beletskii, Liming Lu, Jason Castle
  • Patent number: 7279296
    Abstract: Provided herein are compositions and methods for lipoprotein uptake assay. These compositions and methods may be used for the lipoprotein uptake assays, including high-throughput assays. The disclosed compositions and method may further be used to characterize the activity agents that inhibit or stimulate lipoprotein uptake.
    Type: Grant
    Filed: December 16, 2005
    Date of Patent: October 9, 2007
    Assignee: General Electric Company
    Inventors: Anton Beletskii, Liming Yu, Jason William Castle
  • Publication number: 20070141551
    Abstract: Provided herein are compositions and methods for lipoprotein uptake assay. These compositions and methods may be used for the lipoprotein uptake assays, including high-throughput assays. The disclosed compositions and method may further be used to characterize the activity agents that inhibit or stimulate lipoprotein uptake.
    Type: Application
    Filed: December 16, 2005
    Publication date: June 21, 2007
    Inventors: Anton Beletskii, Liming Yu, Jason Castle
  • Publication number: 20070140974
    Abstract: In some embodiments, the present invention is directed to novel targeted contrast agents for magnetic resonance imaging (MRI). The present invention is also directed to methods of making such targeted MRI contrast agents, and to methods of using such MRI contrast agents. Typically, such targeted MRI contrast agents provide enhanced relaxivity, improved signal-to-noise, targeting ability, and resistance to agglomeration. Methods of making such MRI contrast agents typically afford better control over particle size, and methods of using such MRI contrast agents typically afford enhanced blood clearance rates and biodistribution.
    Type: Application
    Filed: December 15, 2005
    Publication date: June 21, 2007
    Applicant: General Electric Company
    Inventors: Andrew Torres, Faisal Syud, Nichole Wood, Amit Kulkarni, Mark Baillie, Bahram Moasser, Brian Bales, Anton Beletskii, Peter Bonitatebus
  • Publication number: 20070065805
    Abstract: The present invention provides compositions and methods for preparation of a three-dimensional transendothelial cell migration (TEM) assay. These compositions and methods are uniquely suited for the high throughput TEM assay, and for the analysis and identification of TEM mediators which inhibit or stimulate this process. The composition for detecting migration of cells comprises a solid layer comprising collagen gel; a first cellular layer in contact with the solid layer and comprising a first cell type; and a second cell type seeded on top of the first cellular layer. Optionally, gelatin is included in the collagen gel. A 96 well plate format is disclosed, the combination with a high throughput cellular scanner enables high throughput TEM assay.
    Type: Application
    Filed: September 12, 2006
    Publication date: March 22, 2007
    Inventors: Liming Yu, Lihong Zhao, Anton Beletskii, Padma Channavajhala
  • Publication number: 20060093555
    Abstract: The present invention is directed to the field of magnetic resonance imaging (MRI) using superparamagnetic iron oxide (SPIO) agents. In particular, the present invention is directed to cationic, nonagglomerated, nontoxic SPIO agents, methods for imaging conditions associated with inflammatory responses using the disclosed SPIO agents, and methods for managing inflammatory conditions using the disclosed SPIO agents.
    Type: Application
    Filed: November 1, 2005
    Publication date: May 4, 2006
    Inventors: Andrew Torres, Brian Bales, Peter Bonitatebus, Amit Kulkarni, William Dixon, Lisa Schoonmaker, Patrick Malenfant, Anton Beletskii, Matthew Morrison